Trial intelligence / Profile preview

Carisbamate in Korean and Japanese patients with partial onset seizures

NCT00697918Phase 3Completed

Sponsor
SK Life Science, Inc.
Start
Mar 2008
Primary completion
Apr 2009
01

Overview

A Phase 3 trial of carisbamate in focal onset seizure, sponsored by SK Life Science, Inc.. Started Mar 2008; status: completed.

02

Drugs

carisbamate
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT00697918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00697918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call